Probiotic CFU Counts: Why Your Label Claim May Not Survive to the Expiration Date

The US probiotic supplement market crossed $5.8 billion in retail sales in 2024, and every SKU in that market carries a CFU claim. Ten billion live cultures. Fifty billion active organisms. One hundred billion at time of manufacture. These numbers appear on labels, in Amazon listings, and in marketing copy as if they’re fixed, reliable facts.

They’re not. Not without stability data to back them up.

We run probiotic stability studies at our ISO 17025-accredited laboratory in Irvine regularly, and the pattern we see is consistent: products formulated without adequate overage or moisture control frequently lose 90% or more of their viable organisms before the printed expiration date. That’s not a quality control edge case. Under 21 CFR Part 111, it’s a labeling violation — and it’s one of the more common compliance gaps we catch when brands come to us after an Amazon listing suspension or an FDA documentation request.

Why “At Manufacture” vs. “At Expiry” Is the Most Important Distinction in Probiotic Labeling

FDA’s Current Good Manufacturing Practice regulations for dietary supplements (21 CFR Part 111) require that every label claim be substantiated with stability data covering the entire labeled shelf life. A CFU claim is a potency claim — and like any potency claim, it has to be true at the point of consumption, not just the point of production.

This creates two genuinely different labeling strategies that brands often conflate.

At manufacture: The label reflects the CFU count at the time of production. If the product degrades significantly over 24 months, this claim can be literally accurate on day one and meaningless by month 18 when a consumer actually buys it.

At expiry: The label reflects the minimum CFU count that will be present at the printed expiration date. This requires formulating with a built-in overage — typically between 200% and 500% above the label claim at manufacture — to account for organism die-off during storage and distribution.

FDA doesn’t explicitly mandate “at expiry” labeling language, but the agency’s interpretation of 21 CFR Part 101.54 and a series of warning letters issued since 2018 make the requirement clear: potency claims must be supported throughout the labeled shelf life. Brands relying solely on day-zero CFU counts — or worse, relying on the raw ingredient supplier’s Certificate of Analysis without testing the finished, packaged product — are building their compliance documentation on sand.

And Amazon is now asking the right questions. Its supplement compliance program increasingly requests stability data as part of third-party lab documentation, particularly for probiotic products. A 50 billion CFU listing that can’t demonstrate count retention at month 18 is exactly the documentation gap that triggers a listing review or removal.

The Three Variables That Kill Live Cultures Before Your Product Reaches a Consumer

Probiotic organisms are living things, which makes them categorically different from most dietary supplement ingredients. Vitamins degrade on a predictable chemical curve. Botanicals oxidize slowly. But probiotic bacteria die — and the rate at which they die is determined by three environmental variables that interact in ways that are easy to underestimate.

Temperature. Most Lactobacillus and Bifidobacterium strains experience accelerating die-off above 25°C (77°F). Sustained exposure to 30–37°C during warehouse storage or transit can reduce viability by 1–2 log CFU within a matter of weeks. One product we evaluated had lost 99% of its labeled CFU count after a simulated summer shipping scenario — four days at 40°C with ambient humidity. The brand had no idea, because their only testing data was from the day the product left the manufacturer.

Moisture. Water activity (Aw) is arguably the most controllable variable in probiotic formulation, and the one most often underspecified. Most lyophilized (freeze-dried) probiotic strains maintain stability at Aw below 0.25. Once moisture infiltrates the capsule or powder matrix — whether through packaging failures, elevated humidity during encapsulation, or an undersized desiccant packet — cell membranes begin to rehydrate. Organisms come out of their dormant state, burn through stored energy reserves, and die within days to weeks.

Oxygen. Strictly anaerobic organisms like Bifidobacterium species are particularly oxygen-sensitive, and this is the variable brands most frequently under-engineer. Nitrogen-flush packaging and oxygen-scavenging sachets can extend viability significantly, but only if properly validated. We regularly test finished products where the desiccant and oxygen scavenger inside the bottle are undersized for the actual headspace volume — a detail that’s nearly impossible to catch without real-time stability testing on the finished package configuration.

The interaction effects among these three variables are non-linear. A product that’s marginally acceptable on each individual parameter can fail catastrophically when all three are even slightly off simultaneously. This is why stability testing has to be done on the finished, packaged product as it will actually be sold — not on the bulk powder, not on the raw ingredient, and not in idealized laboratory conditions that don’t reflect your actual supply chain.

What a Defensible Probiotic Stability Testing Protocol Looks Like

Here’s where brands — especially smaller DTC operators and Amazon-first sellers — consistently take shortcuts that cost them later.

A minimum defensible stability program for a probiotic dietary supplement includes the following:

Baseline (T=0) enumeration. Full viability testing using USP General Chapter <2021> (Enumeration of Microbial Counts) or its ISO 4833 equivalent. This establishes your starting CFU count per the finished product specification. The key word is finished: testing should be done on product in its final packaging configuration, after any nitrogen-flush, desiccant placement, and induction sealing steps are complete.

Accelerated stability screening (ICH Q1A conditions). Testing at 40°C / 75% relative humidity at 3-month and 6-month intervals. Accelerated data lets you make provisional shelf-life claims while real-time data accumulates. For probiotics specifically, though, accelerated stability data has meaningful limitations — the stress conditions can kill organisms faster than predictive models suggest, making accelerated data far less reliable than it is for chemically-defined ingredients. We treat accelerated data as a red-flag screen, not as a substitute for real-time studies.

Real-time stability at intended storage conditions. Most room-temperature probiotic products are labeled for storage at controlled room temperature (68–77°F / 20–25°C). Real-time data at 12 months, 18 months, and 24 months is what ultimately substantiates a 24-month shelf life claim. For refrigerated products, the storage condition in the study has to match exactly what the label instructs — there’s no regulatory flexibility here.

Strain identity confirmation. CFU enumeration alone doesn’t confirm that the surviving organisms are the strains claimed on the label. qPCR-based methods or 16S rRNA gene sequencing are needed to confirm strain identity at each stability timepoint. This matters especially for products making structure/function claims tied to specific clinical evidence — the research backing Lactobacillus acidophilus NCFM doesn’t transfer to a different lactobacillus strain just because it survived the stability study.

The cost of a complete real-time stability program — baseline testing plus annual timepoints through 24 months — typically runs $3,000–$8,000 per SKU, depending on the number of strains and test methods required. That’s a real line item for a small brand. It’s also a fraction of the cost of an FDA warning letter, a consumer class action over label misrepresentation, or a lost Amazon listing during Q4.

Before Your Next Production Run: A Practical Checklist

If your probiotic is already on the market and your stability data is thin, here’s where to start.

Pull finished product samples from your most recent production lot and initiate T=0 testing now. Don’t wait for a regulatory trigger. You need a current, verified baseline to know where you actually stand.

Review your packaging specifications. Are you using HDPE bottles with induction seals and validated desiccant packets? If you’re using foil pouches, do you have oxygen-transmission-rate data for the film from the packaging supplier? Is the desiccant capacity sized for the actual headspace volume of your bottle, not just the number of capsules?

Audit your label claim against your formulation. If the label says “at time of manufacture,” document exactly when that claim was established and with what testing. If the label implies count at expiry — or if your marketing materials make that implication — you need stability data that supports it.

Ask your contract manufacturer for the overage factor used in your formulation. A 100 billion CFU label claim with a 300% overage (300 billion CFU at manufacture) can handle typical die-off for a well-packaged room-temperature product through 24 months. The same label claim built on a 115% overage is almost certainly going to fail before it reaches the consumer who buys it on month 20 of a 24-month shelf life.

Getting this right isn’t just about avoiding warning letters or Amazon delistings — though both of those matter. It’s about whether the consumers buying your product are actually getting what you’re claiming. For a category built on the promise of viable, active organisms, the gap between label and reality is both a compliance problem and a credibility problem. And in the probiotic market, credibility is hard to recover once it’s gone.

---

Written by Nour Abochama, Vice President of Operations, Qalitex Laboratories. Learn more about our team

Talk to our team about your testing needs. Contact us

Related from our network

• FDA GMP Audit Preparation for Supplement Manufacturers — Aurora TIC’s regulatory consultants help supplement companies build the documentation systems that support 21 CFR Part 111 compliance, including stability program design and audit readiness.
• Raw Probiotic Ingredient Testing Against USP and Ph.Eur. Monographs — Ayah Labs provides contract testing for probiotic raw materials, including microbial enumeration, strain identity confirmation, and supplier qualification support.